Kathmandu, June 26 -- In a major crackdown on illicit and counterfeit drugs being sold in Nepal under the name of a leading Indian pharmaceutical company, the Department of Drug Administration has seized a huge quantity of medicine from various places across the country this week.

The department, the national regulatory body for pharmaceutical products, said its inspectors seized counterfeit Seroflo Rotacaps 250 from multiple wholesale stores in Kathmandu, and one each in Lalitpur, Rupendehi and Kailali.

Seroflo Rotacaps 250 is a salmeterol and fluticasone propionate powder for inhalation officially manufactured by Sikkim-based CIPLA LTD, a leading pharmaceutical company in India.

It is an asthma medicine widely prescribed by pulmonolo...